We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+40.55%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.47B
AUM Growth
+$207M
Cap. Flow
-$137M
Cap. Flow %
-9.32%
Top 10 Hldgs %
9.07%
Holding
898
New
262
Increased
152
Reduced
230
Closed
245

Top Buys

Rank Stock Value
1
BE icon
Bloom Energy
BE
+$9.29M
2
ZEN
ZENDESK INC
ZEN
+$9.24M
3
NTAP icon
NetApp
NTAP
+$8.82M
4
BFAM icon
Bright Horizons
BFAM
+$8.68M
5
LLY icon
Eli Lilly
LLY
+$8.53M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$31.8M
2
HUM icon
Humana
HUM
+$24.8M
3
EOG icon
EOG Resources
EOG
+$17.3M
4
DINO icon
HF Sinclair
DINO
+$9.96M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.7M

Sector Composition

Rank Sector Weight
1 Technology 23.74%
2 Healthcare 23.44%
3 Consumer Discretionary 13.66%
4 Industrials 10.93%
5 Financials 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WORK
276
DELISTED
Slack Technologies, Inc.
WORK
$1.05M 0.07%
+33,851
New +$1.02M
AAOI icon
277
Applied Optoelectronics
AAOI
$7.07B
$1.05M 0.07%
96,536
-12,190
-11% -$112K
ROL icon
278
Rollins
ROL
$18.8B
$1.05M 0.07%
+37,073
New +$992K
ANET icon
279
Arista Networks
ANET
$214B
$1.03M 0.07%
78,672
+19,472
+33% +$263K
OKTA icon
280
Okta
OKTA
$23.7B
$1.03M 0.07%
5,160
+171
+3% +$29K
CRBP icon
281
Corbus Pharmaceuticals
CRBP
$168M
$1.03M 0.07%
+4,082
New +$825K
PRLB icon
282
Protolabs
PRLB
$1.78B
$1.02M 0.07%
9,108
+8
+0.1% +$821
COKE icon
283
Coca-Cola Consolidated
COKE
$13B
$1.01M 0.07%
44,010
-25,000
-36% -$585K
MTRN icon
284
Materion
MTRN
$4.36B
$996K 0.07%
16,200
-6,325
-28% -$320K
HUBS icon
285
HubSpot
HUBS
$12.2B
$993K 0.07%
+4,425
New +$796K
GTHX
286
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$993K 0.07%
+40,919
New +$677K
RDUS
287
DELISTED
Radius Health, Inc.
RDUS
$975K 0.07%
71,570
+43
+0.1% +$592
SMG icon
288
ScottsMiracle-Gro
SMG
$4.25B
$962K 0.07%
+7,151
New +$923K
ELV icon
289
Elevance Health
ELV
$83.7B
$950K 0.06%
+3,614
New +$964K
MIC
290
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$945K 0.06%
+30,785
New +$852K
WWE
291
DELISTED
World Wrestling Entertainment
WWE
$943K 0.06%
21,702
+288
+1% +$12.4K
RNG icon
292
RingCentral
RNG
$4.77B
$942K 0.06%
3,306
+1,883
+132% +$476K
TCDA
293
DELISTED
Tricida, Inc. Common Stock
TCDA
$941K 0.06%
34,246
-4,554
-12% -$124K
CTMX icon
294
CytomX Therapeutics
CTMX
$701M
$937K 0.06%
112,519
+33,819
+43% +$314K
ROKU icon
295
Roku
ROKU
$21.3B
$933K 0.06%
+8,010
New +$916K
SRE icon
296
Sempra
SRE
$59.2B
$928K 0.06%
+15,834
New +$973K
GOOS
297
Canada Goose Holdings
GOOS
$903M
$925K 0.06%
+39,919
New +$887K
VECO icon
298
Veeco
VECO
$2.79B
$922K 0.06%
68,378
+17,106
+33% +$196K
RDNT icon
299
RadNet
RDNT
$4.97B
$904K 0.06%
56,969
+8,889
+18% +$129K
FNV icon
300
Franco-Nevada
FNV
$40.6B
$884K 0.06%
+6,327
New +$841K

Similar funds

PDT Partners's Q2 2020 Portfolio in Review

As of Q2 2020, PDT Partners held 898 positions worth $1.47B, up 16% from $1.26B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

PDT Partners withdrew a net $137M in Q2 2020, closing 245 positions and reducing 230 holdings. Its most notable exit was AbbVie, an estimated $31.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in ZENDESK INC worth $10.6M.

  • PDT Partners's largest Q2 2020 buy was ZENDESK INC: 119,997 shares worth $10.6M.
  • PDT Partners added most to Bloom Energy in Q2 2020, an estimated $9.29M increase.
  • PDT Partners's biggest Q2 2020 reduction was EOG Resources, cutting an estimated $17.3M.
  • PDT Partners fully exited AbbVie in Q2 2020, selling an estimated $31.8M.
  • PDT Partners's ten largest holdings make up 9.1% of its $1.47B portfolio in Q2 2020.
  • PDT Partners opened 262 new positions and closed 245 in Q2 2020.
  • PDT Partners's portfolio value rose 16% quarter-over-quarter to $1.47B.

Based on PDT Partners's 13F filing for Q2 2020, filed 14 Aug 2020.